Dr Reddy’s Eyes Generic Revlimid Exclusivity With ANDA Approval

Follows Natco ANDA Approval Earlier This Year; Market To Form In Months

 
• By Dean Rudge
  
Firms Await Regulatory Inspections
BMS anticipates 'more of a slope than a cliff' • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products